{"id":41175,"date":"2025-09-11T16:35:41","date_gmt":"2025-09-11T08:35:41","guid":{"rendered":"https:\/\/flcube.com\/?p=41175"},"modified":"2025-09-11T16:35:41","modified_gmt":"2025-09-11T08:35:41","slug":"yoltech-raises-300-million-yuan-series-b-pushing-in%e2%80%91vivo-gene%e2%80%91editing-to-the-forefront","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=41175","title":{"rendered":"YolTech Raises 300\u202fMillion Yuan Series\u202fB, Pushing In\u2011Vivo Gene\u2011Editing to the Forefront"},"content":{"rendered":"\n<p>The AstraZeneca\u2011CICC Medical Industry Fund announced that it led a <strong>Series\u202fB financing round<\/strong> for China\u2011based <strong>YolTech Therapeutics<\/strong>, raising <strong>over 300\u202fmillion yuan<\/strong> (\u2248\u202f$45\u202fmillion). The round also attracted <strong>Green Pine Capital Partners, Tianjin Venture, and Xinneng Ventures<\/strong>. Follow\u2011on commitments from <strong>K2 Venture Partners, Grand Flight Investment, and Decheng Capital<\/strong> pushed YolTech\u2019s cumulative funding to <strong>above 575\u202fmillion yuan<\/strong>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-why-this-matters\">Why This Matters<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Capital Infusion<\/strong><\/td><td>300\u202fm+\u202fyuan (~$45\u202fm) fuels continued pipeline development<\/td><\/tr><tr><td><strong>Investor Mix<\/strong><\/td><td>Global (AstraZeneca\u2011CICC) + domestic venture capital backing<\/td><\/tr><tr><td><strong>Funding Milestone<\/strong><\/td><td>Total &gt;\u202f575\u202fm yuan, the highest for an in\u2011vivo gene\u2011editing biopharma<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-yoltech-s-technological-edge\">YolTech\u2019s Technological Edge<\/h2>\n\n\n\n<p>YolTech has positioned itself as the <strong>global leader in clinical\u2011stage in\u2011vivo gene\u2011editing drugs<\/strong>. Its platform hinges on <strong>messenger\u2011RNA (mRNA) coupled with lipid\u2011nanoparticle (LNP) delivery<\/strong>\u2014a highly specific, non\u2011viral system that can edit genes directly within living cells.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Four Active Pipelines<\/strong> \u2013 All have entered clinical trials, covering a range of monogenic disorders.<\/li>\n\n\n\n<li><strong>mRNA\u2011LNP Delivery<\/strong> \u2013 Enables efficient, site\u2011specific gene editing with minimal off\u2011target effects.<\/li>\n\n\n\n<li><strong>Clinical\u2011Stage Leadership<\/strong> \u2013 More in\u2011vivo gene\u2011editing candidates in human trials than any other company worldwide.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-amp-competitive-landscape\">Market &amp; Competitive Landscape<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Regulatory Progress<\/strong> \u2013 Several of YolTech\u2019s candidates are in Phase\u202f1\/2 studies, with regulatory submissions underway in China and the U.S.<\/li>\n\n\n\n<li><strong>Strategic Partnerships<\/strong> \u2013 The AstraZeneca\u2011CICC lead signals potential future collaboration with major pharma players.<\/li>\n\n\n\n<li><strong>Investment Trend<\/strong> \u2013 The biotech sector is witnessing a surge in funding for next\u2011generation therapeutics; YolTech\u2019s raise underscores confidence in mRNA\u2011LNP gene\u2011editing.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-future-outlook\">Future Outlook<\/h2>\n\n\n\n<p>With the Series\u202fB round complete, YolTech plans to accelerate pre\u2011clinical work, expand clinical cohorts, and pursue regulatory approvals across key markets. The funding also positions the company to explore <strong>beyond\u2011gene\u2011editing<\/strong> applications, such as mRNA\u2011based vaccines and immunotherapies.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The AstraZeneca\u2011CICC Medical Industry Fund announced that it led a Series\u202fB financing round for China\u2011based&#8230;<\/p>\n","protected":false},"author":1,"featured_media":41177,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[66,1168],"class_list":["post-41175","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-gene-therapy","tag-yoltech-therapeutics"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>YolTech Raises 300\u202fMillion Yuan Series\u202fB, Pushing In\u2011Vivo Gene\u2011Editing to the Forefront - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"The AstraZeneca\u2011CICC Medical Industry Fund announced that it led a Series\u202fB financing round for China\u2011based YolTech Therapeutics, raising over 300\u202fmillion yuan (\u2248\u202f$45\u202fmillion). The round also attracted Green Pine Capital Partners, Tianjin Venture, and Xinneng Ventures. Follow\u2011on commitments from K2 Venture Partners, Grand Flight Investment, and Decheng Capital pushed YolTech\u2019s cumulative funding to above 575\u202fmillion yuan.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=41175\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"YolTech Raises 300\u202fMillion Yuan Series\u202fB, Pushing In\u2011Vivo Gene\u2011Editing to the Forefront\" \/>\n<meta property=\"og:description\" content=\"The AstraZeneca\u2011CICC Medical Industry Fund announced that it led a Series\u202fB financing round for China\u2011based YolTech Therapeutics, raising over 300\u202fmillion yuan (\u2248\u202f$45\u202fmillion). The round also attracted Green Pine Capital Partners, Tianjin Venture, and Xinneng Ventures. Follow\u2011on commitments from K2 Venture Partners, Grand Flight Investment, and Decheng Capital pushed YolTech\u2019s cumulative funding to above 575\u202fmillion yuan.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=41175\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-11T08:35:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1109.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41175#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41175\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"YolTech Raises 300\u202fMillion Yuan Series\u202fB, Pushing In\u2011Vivo Gene\u2011Editing to the Forefront\",\"datePublished\":\"2025-09-11T08:35:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41175\"},\"wordCount\":316,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41175#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/1109.webp\",\"keywords\":[\"Gene therapy\",\"YolTech Therapeutics\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=41175#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41175\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=41175\",\"name\":\"YolTech Raises 300\u202fMillion Yuan Series\u202fB, Pushing In\u2011Vivo Gene\u2011Editing to the Forefront - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41175#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41175#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/1109.webp\",\"datePublished\":\"2025-09-11T08:35:41+00:00\",\"description\":\"The AstraZeneca\u2011CICC Medical Industry Fund announced that it led a Series\u202fB financing round for China\u2011based YolTech Therapeutics, raising over 300\u202fmillion yuan (\u2248\u202f$45\u202fmillion). The round also attracted Green Pine Capital Partners, Tianjin Venture, and Xinneng Ventures. Follow\u2011on commitments from K2 Venture Partners, Grand Flight Investment, and Decheng Capital pushed YolTech\u2019s cumulative funding to above 575\u202fmillion yuan.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41175#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=41175\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41175#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/1109.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/1109.webp\",\"width\":1080,\"height\":608,\"caption\":\"YolTech Raises 300\u202fMillion Yuan Series\u202fB, Pushing In\u2011Vivo Gene\u2011Editing to the Forefront\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41175#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"YolTech Raises 300\u202fMillion Yuan Series\u202fB, Pushing In\u2011Vivo Gene\u2011Editing to the Forefront\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"YolTech Raises 300\u202fMillion Yuan Series\u202fB, Pushing In\u2011Vivo Gene\u2011Editing to the Forefront - Insight, China&#039;s Pharmaceutical Industry","description":"The AstraZeneca\u2011CICC Medical Industry Fund announced that it led a Series\u202fB financing round for China\u2011based YolTech Therapeutics, raising over 300\u202fmillion yuan (\u2248\u202f$45\u202fmillion). The round also attracted Green Pine Capital Partners, Tianjin Venture, and Xinneng Ventures. Follow\u2011on commitments from K2 Venture Partners, Grand Flight Investment, and Decheng Capital pushed YolTech\u2019s cumulative funding to above 575\u202fmillion yuan.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=41175","og_locale":"en_US","og_type":"article","og_title":"YolTech Raises 300\u202fMillion Yuan Series\u202fB, Pushing In\u2011Vivo Gene\u2011Editing to the Forefront","og_description":"The AstraZeneca\u2011CICC Medical Industry Fund announced that it led a Series\u202fB financing round for China\u2011based YolTech Therapeutics, raising over 300\u202fmillion yuan (\u2248\u202f$45\u202fmillion). The round also attracted Green Pine Capital Partners, Tianjin Venture, and Xinneng Ventures. Follow\u2011on commitments from K2 Venture Partners, Grand Flight Investment, and Decheng Capital pushed YolTech\u2019s cumulative funding to above 575\u202fmillion yuan.","og_url":"https:\/\/flcube.com\/?p=41175","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-09-11T08:35:41+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1109.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=41175#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=41175"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"YolTech Raises 300\u202fMillion Yuan Series\u202fB, Pushing In\u2011Vivo Gene\u2011Editing to the Forefront","datePublished":"2025-09-11T08:35:41+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=41175"},"wordCount":316,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=41175#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1109.webp","keywords":["Gene therapy","YolTech Therapeutics"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=41175#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=41175","url":"https:\/\/flcube.com\/?p=41175","name":"YolTech Raises 300\u202fMillion Yuan Series\u202fB, Pushing In\u2011Vivo Gene\u2011Editing to the Forefront - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=41175#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=41175#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1109.webp","datePublished":"2025-09-11T08:35:41+00:00","description":"The AstraZeneca\u2011CICC Medical Industry Fund announced that it led a Series\u202fB financing round for China\u2011based YolTech Therapeutics, raising over 300\u202fmillion yuan (\u2248\u202f$45\u202fmillion). The round also attracted Green Pine Capital Partners, Tianjin Venture, and Xinneng Ventures. Follow\u2011on commitments from K2 Venture Partners, Grand Flight Investment, and Decheng Capital pushed YolTech\u2019s cumulative funding to above 575\u202fmillion yuan.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=41175#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=41175"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=41175#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1109.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1109.webp","width":1080,"height":608,"caption":"YolTech Raises 300\u202fMillion Yuan Series\u202fB, Pushing In\u2011Vivo Gene\u2011Editing to the Forefront"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=41175#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"YolTech Raises 300\u202fMillion Yuan Series\u202fB, Pushing In\u2011Vivo Gene\u2011Editing to the Forefront"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1109.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/41175","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=41175"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/41175\/revisions"}],"predecessor-version":[{"id":41178,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/41175\/revisions\/41178"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/41177"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=41175"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=41175"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=41175"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}